Summary
PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease indication.
Register to download
Multi-stakeholder Collaboration Achieves Rapid Study Start-up for an Advanced Therapeutic
You may also be interested in:
Blog
Winning Team: Working With a Service Dog
Read Story
Capability
ECG Assessments During the Development of Oncology Compounds
Single-center oncology studies performed by dedicated PRA staff, combined with the High Precision QT approach of iCardiac, generates conclusive ECG…
View Resource
Poster
Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Phase 1 Studies in Subjects with Stable Schizophrenia
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in meta-analysis to be as high as 76% (Robinowitz…
View Resource
View all related content and resources for Scientific Affairs
Explore Insights